Health claims about US cannabis products with Tim Mackey and Doug Roehler

Health claims about US cannabis products with Tim Mackey and Doug Roehler

In this episode, Dr Elle Wadsworth talks to Dr Tim Mackey and Dr Doug Roehler. Tim is a professor in the Global Health Program at UC San Diego and the CEO and co-founder of S-3 Research, and Doug is the Cannabis Research Unit lead in the Department of Policy and Research for California’s Department of Cannabis Control. The interview covers Tim and Doug’s research article exploring the health benefit claims of cannabis products on online marketplaces in the United States.

  • Why exploring health benefit claims on cannabis products was an important topic to investigate [01:20]
  • What are cannabis-derived products? [03:07]
  • What are the online marketplaces ‘Leafly’ and ‘Weedmaps’? [03:35]
  • Examples of health benefit claims [05:00]
  • The main findings of the study [07:33]
  • The cannabis regulatory environment in the US [10:20]
  • The differences in health claims between different types of cannabis products [12:20]
  • The methodology used in the study that brought together data scientists and public health researchers [14:11]
  • The health claims that surprised Tim and Doug [18:31]


About Elle Wadsworth: Elle is an academic fellow with the Society for the Study of Addiction. She is based at the University of Bath with the Addiction and Mental Health Group and her research interests include drug policy, cannabis legalisation, and public health. She has a BSc in Chemistry, an MSc in Addiction Studies, and a PhD in Public Health.

About Tim Ken Mackey: Tim is a Professor in the Global Health Program at UC San Diego and the CEO and co-founder of S-3 Research, a public health data science company originally created from a Challenge.gov award. He is also the Director of the Global Health Policy and Data Institute and the Editor-in-Chief of JMIR Infodemiology. He has co-authored over 270 manuscripts on topics including global health, technology, data science, substance use disorder, and health policy. Dr Mackey is an entrepreneur and scientist working on technology innovation to address public health challenges.

About Douglas Roehler: Doug leads the Cannabis Research Unit in the Department of Policy and Research for California’s Department of Cannabis Control. Previously, he was a health scientist and epidemiologist in the Division of Overdose Prevention at the CDC, where he primarily served in the CDC’s Cannabis Strategy Unit. He has published extensively on cannabis topics in peer-reviewed journals and governmental reports, appeared on national podcasts, and represented the CDC in the national media. He has published widely on several other topics, including injury prevention, drug overdose and substance use, youth prevention, syndromic surveillance, traffic crashes, and youth violence.

Declarations of Interest: Tim Mackey is the CEO and co-founder of the company S-3 Research and holds equity/ownership in the company. S-3 Research is a small business that has received funding through government contracts and grants for professional and technology services including on topics related to substance use disorder.


Original article: Exploratory analysis of United States-based cannabis product health benefit claims on online marketplaces https://doi.org/10.1111/add.70177

The opinions expressed in this podcast reflect the views of the host and interviewees and do not necessarily represent the opinions or official positions of the SSA or Addiction journal.

The SSA does not endorse or guarantee the accuracy of the information in external sources or links and accepts no responsibility or liability for any consequences arising from the use of such information.

Hosted on Acast. See acast.com/privacy for more information.

Avsnitt(108)

Changes in cannabis with Tom Freeman

Changes in cannabis with Tom Freeman

Suzi Gage speaks to Dr. Tom Freeman, director of the Addiction and Mental Health Group at the University of Bath, about his research into how the THC and CBD content of cannabis products has changed over the years.You can read Tom's research here https://onlinelibrary.wiley.com/doi/10.1111/add.15253 Hosted on Acast. See acast.com/privacy for more information.

20 Nov 20209min

Reefer Madness with Wayne Hall

Reefer Madness with Wayne Hall

Suzi Gage talkes to Wayne Hall about his analysis of the film Reefer Madness for the Addiction Classics series.The Addiction Classics series gives authors an opportunity to reflect on what classic works (usually books or research papers but in this case a film) have contributed to the addiction field, and why we need to be aware of them. A Virtual Issue of all articles published so far in the series can be accessed online at https://onlinelibrary.wiley.com/doi/10.1111/add.13530Wayne Hall's paper can be accessed here https://onlinelibrary.wiley.com/share/DXNJ95VNTCFU9FGCH7WU?target=10.1111/add.15258 Hosted on Acast. See acast.com/privacy for more information.

2 Okt 202015min

Addiction News with Rob Calder

Addiction News with Rob Calder

Suzi talks to Dr Rob Calder about Addiction News and COVID-19 addiction news from across the globe. Addiction News is an area on the journal website where Rob has been compiling news articles and stories related to addiction. Rob is the Deputy Web Editor for the Society for the Study of Addiction, as well as the editor of Addiction News. We talk about the page itself, as well as news stories about addiction and COVID, in particular around changing policies and changing treatment options for people who use drugs.The Addiction News pages can be found here: https://www.addictionjournal.org/newsroom/news Hosted on Acast. See acast.com/privacy for more information.

25 Juni 202019min

Smoking and COVID-19 with Olga Perski

Smoking and COVID-19 with Olga Perski

Suzi Gage talks to Dr Olga Perski about evidence around the relationship between smoking and COVID-19, why there may have been some disagreement in the literature and the media as to the relationship, and her work conducting a living systematic review to explore this further.The living systematic review can be found here, for pre-publication peer review and comment: https://www.qeios.com/read/UJR2AWPerski has also written this rapid evidence review on the topic: https://www.qeios.com/read/VGJCUN Hosted on Acast. See acast.com/privacy for more information.

3 Maj 202024min

GHB with Shalini Arunogiri

GHB with Shalini Arunogiri

Suzi Gage interviews Shalini Arunogiri about her research on GHB-related harmsThe research can be found here: onlinelibrary.wiley.com/doi/10.1111/add.14848Arunogiri, S., Moayeri, F., Crossin, R., Killian, J. J., Smith, K., Scott, D., and Lubman, D. I. ( 2020) Trends in gamma‐hydroxybutyrate‐related harms based on ambulance attendances from 2012 to 2018 in Victoria, Australia. Addiction, 115: 473– 479. https://doi.org/10.1111/add.14848. Hosted on Acast. See acast.com/privacy for more information.

3 Maj 202011min

Characteristics of English smokers with Claire Garnett

Characteristics of English smokers with Claire Garnett

Suzi Gage interviews Dr Claire Garnett about her research exploring changes in smoking and quitting behaviour in EnglandThe research article can be found here: https://onlinelibrary.wiley.com/doi/full/10.1111/add.14882Garnett, C., Tombor, I., Beard, E., Jackson, S. E., West, R., and Brown, J. ( 2020) Changes in smoker characteristics in England between 2008 and 2017. Addiction, 115: 748– 756. https://doi.org/10.1111/add.14882. Hosted on Acast. See acast.com/privacy for more information.

3 Maj 20206min

Global Drug Survey with Adam Winstock

Global Drug Survey with Adam Winstock

Suzi Gage interviews Adam Winstock about the Global Drug SurveyGlobal Drug Survey's website is here: https://www.globaldrugsurvey.com/ Hosted on Acast. See acast.com/privacy for more information.

3 Maj 20206min

Incentives for alcohol screening in primary care with Amy O'Donnell

Incentives for alcohol screening in primary care with Amy O'Donnell

Suzi Gage interviews Amy O'Donnell about her research on the impact of introducing and then withdrawing small financial incentives for alcohol screening and brief advice in primary care in EnglandThe research can be read here: https://onlinelibrary.wiley.com/doi/full/10.1111/add.14778O'Donnell, A., Angus, C., Hanratty, B., Hamilton, F. L., Petersen, I., and Kaner, E. ( 2020) Impact of the introduction and withdrawal of financial incentives on the delivery of alcohol screening and brief advice in English primary health care: an interrupted time–series analysis. Addiction, 115: 49– 60. https://doi.org/10.1111/add.14778. Hosted on Acast. See acast.com/privacy for more information.

3 Maj 202019min

Populärt inom Vetenskap

p3-dystopia
dumma-manniskor
allt-du-velat-veta
svd-nyhetsartiklar
kapitalet-en-podd-om-ekonomi
rss-ufobortom-rimligt-tvivel
rss-vetenskapspodden
sexet
paranormalt-med-caroline-giertz
rss-i-hjarnan-pa-louise-epstein
rss-vetenskapsradion
rss-spraket
bildningspodden
rss-personlighetspodden
rss-vetenskapsradion-2
dumforklarat
rss-broccolipodden-en-podcast-som-inte-handlar-om-broccoli
barnpsykologerna
medicinvetarna
pojkmottagningen